MONIRO-1
MONIRO-1 is a T-type and N-type calcium channel blocker with IC50 values of 34, 3.3, 1.7 and 7.2 µM against hCav2.2, hCav3.1, hCav3.2 and hCav3.3, respectively. MONIRO-1 has low activity against L-type calcium channels. MONIRO-1 can be used for the study of pain and epilepsy[1].
Product Specifications
CAS Number
1909225-94-0
UNSPSC
12352005
Target
Calcium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/moniro-1.html
Purity
99.18
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
N/C(N)=N\CCCOC1=CC=C(C=C1)C(NC2=C(C=CC=C2)OC3=CC=C(C=C3)F)=O.Cl
Molecular Formula
C23H24ClFN4O3
Molecular Weight
458.91
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
N-type calcium channel; T-type calcium channel
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SIRP alpha (Signal Regulatory Protein alpha, SIRPalpha, SIRPA, SIRP, Signal-regulatory Protein alpha-1, Sirp-alpha-1, Signal-regulatory Protein alpha-2, Sirp-alpha-2, Signal-regulatory Protein alpha-3, Sirp-alpha-3, Brain Ig-like Molecule with Tyrosine-based Activation Motifs, Bit, CD172 Antigen-like Family Member A, CD172a, Inhibitory Receptor SHPS-1, Macrophage Fusion Receptor, MFR, MyD-1 Antigen, MYD1, MYD-1, p84, PTPNS1, SHP Substrate 1, SHPS1, SHPS-1, Tyrosine-protein Phosphatase Non-receptor Type Substrate 1) (AP) discontinued
